Mesoblast Limited
MESO
$10.64
-$0.96-8.28%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.76% | 4.23% | 12.47% | 17.85% | 13.06% |
| Total Depreciation and Amortization | -19.55% | -13.97% | -8.46% | -14.49% | -2.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 139.38% | 85.78% | 70.22% | 37.43% | 29.83% |
| Change in Net Operating Assets | 113.45% | 94.15% | 57.11% | -52.62% | -278.66% |
| Cash from Operations | 43.54% | 42.05% | 39.06% | 30.26% | 0.30% |
| Capital Expenditure | 41.16% | 8.47% | 10.86% | 14.17% | -25.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 173.38% | 103.13% | 27.01% | 129.76% | 297.97% |
| Cash from Investing | 3,533.33% | 3,356.25% | 41.92% | 66.74% | 95.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -241.93% | -280.67% | -305.09% | -199.74% | -14.26% |
| Issuance of Common Stock | -67.53% | -27.12% | -26.21% | 113.31% | 84.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 43.54% | 20.92% | 12.78% | -14.05% | -32.20% |
| Cash from Financing | -93.28% | -52.97% | -44.06% | 141.01% | 111.05% |
| Foreign Exchange rate Adjustments | -264.74% | -186.87% | 75.45% | 259.53% | 537.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -344.85% | 19.89% | -5.15% | 145.87% | 80.39% |
